S. Luong et al.
[17] B.-S. Huang, Y. Lu, B.-Y. Ji, A. P. Christodoulou. Preparation of
Oxycodone from Codeine. Penick Corporation, New Jersey, 1999.
[18] A. H. Wu, B. Bristol, K. Sexton, G. C. Mclane, V. Holtman,
D. W. Hill. Adulteration of urine by by Urine Luck. Clin.
Chem. 1999, 45, 1051.
[19] P. Lafolie, O. Beck, Z. Lin, F. Albertioni, L. Boreus. Urine
and plasma pharmacokinetics of codeine in healthy
volunteers: implications for drugs-of-abuse testing. J. Anal.
Toxicol. 1996, 20, 541.
[20] G. Ceder, A. W. Jones. Concentration ratios of morphine to
codeine in blood of impaired drivers as evidence of heroin use
and not medication with codeine. Clin. Chem. 2001, 47, 1980.
[21] J. Bu, C. Zhan, Y. Huang, B. Shen, X. Zhuo. Distinguishing
heroin abuse from codeine administration in the urine of
chinese people by UPLC-MS-MS. J. Anal. Toxicol. 2013, 37, 166.
[22] Y.J. He, J. Brockmoller, H. Schmidt, I. Roots, J. Kirchheiner.
CYP2D6 ultrarapid metabolism and morphine/codeine
ratios in blood: was it codeine or heroin? J. Anal. Toxicol.
2008, 32, 178.
[23] D. A. Yee, R. S. Atayee, B. M. Best, J. D. Ma. Observations on
the urine metabolic profile of codeine in pain patients.
J. Anal. Toxicol. 2014, 38, 86.
[24] R. M. Berg-Pedersen, A. Ripel, R. Karinen, M. Vevelstad,
L. Bachs, V. Vindenes. Codeine to morphine concentration
ratios in samples from living subjects and autopsy cases
after incubation. J. Anal. Toxicol. 2014, 38, 99.
[25] J. McMurry. Organic Chemistry. Thompson Brooks/Cole,
California, 2004.
[26] R. J. Fessenden, J. S. Fessenden. Organic Chemistry. PWS
Publishers, Massachusetts, 1982.
[27] R. B. Barber, H. Rapoport. Conversion of thebaine to
codeine. J. Med. Chem. 1976, 19, 1175.
[28] K. Raith, R. Neubert. Electrospray tandem mass
spectrometric investigations of morphinans. J. Am. Soc. Mass
Spectrom. 2003, 14, 1262.
[29] A. Wick, M. Wagner, T. A. Ternes. Elucidation of the
transformation pathway of the opium alkaloid codeine in
biological wastewater treatment. Environ. Sci. Technol. 2011,
45, 3374.
[30] Agilent Technologies Inc. 6510 Q-TOF Final Specifications.
October, 2006.
[31] S. Archer, A. Seyed-Mozaffari, S. Ward, H. W. Kosterlitz,
S. J. Paterson, A. T. McKnight, A. D. Corbett. 10-Ketonaltrexone
and 10-ketooxymorphone. J. Med. Chem. 1985, 28, 974.
[32] A. Coop, K. C. Rice. Studies into the direct oxidation
of codeinone to 14-hydroxycodeinone. Tetrahedron 1999,
55, 11429.
[33] F.-T. Chiu, Y. S. Lo. Method for Preparing Oxycodone.
Boehringer Ingelheim Chemicals Inc., Virginia, 2002.
[34] M. A. Schwartz, R. A. Wallace. Efficient synthesis of
14-hydroxymorphinans from codeine. J. Med. Chem. 1981,
24, 1525.
[35] D. L. Lister, G. Kanungo, D. A. Rathbone, N. C. Bruce.
Transformations of codeine to important semisynthetic
opiate derivatives by Pseudomonas putida M10. FEMS
Microbiol. Lett. 1999, 181, 137.
[36] R. Bruckner. Organic Mechanisms: Reactions, Stereochemistry
and Synthesis. Springer-Verlag, Berlin Heidelberg, 2010.
[37] M. B. Smith, J. March. March’s Advanced Organic
Chemistry: Reactions, Mechanisms and Structure. John Wiley,
New Jersey, 2007.
Acknowledgement
The authors would like to acknowledge John Stathopoulos
(Drug Toxicology Unit, NSW Forensic and Analytical Science
Service) for his assistance with gathering immunoassay and
GC/MS data for this study.
REFERENCES
[1] J. T. Cody, S. Valtier. Effects of Stealth adulterant on
immunoassay testing for drugs of abuse. J. Anal. Toxicol.
2001, 25, 466.
[2] A. Dasgupta. The effects of adulterants and selected
ingested compounds on drugs-of-abuse testing in urine.
Am. J. Clin. Pathol. 2007, 128, 491.
[3] B. D. Paul, A. Jacobs. Effects of oxidizing adulterants on
detection of 11-nor-Δ9-THC-9-carboxylic acid in urine.
J. Anal. Toxicol. 2002, 26, 460.
[4] A. H. B. Wu. Urine adulteration and substitution prior to
drugs of abuse testing. J. Clin. Ligand Assay 2003, 26, 11.
[5] U. Kuzhiumparambil, S. Fu. Effect of oxidizing adulterants
on human urinary steroid profiles. Steroids 2013, 78, 288.
[6] U. Kuzhiumparambil, S. Fu. Effect of hydrogen peroxide
oxidation systems on human urinary steroid profiles. Anal.
Methods 2013, 5, 4402.
[7] S. Luong, R. Shimmon, J. Hook, S. Fu. 2-Nitro-6-
monoacetylmorphine: potential marker for monitoring the
presence of 6-monoacetylmorphine in urine adulterated
with potassium nitrite. Anal. Bioanal. Chem. 2012, 403, 2057.
[8] S. Luong, S. Fu. Detection and identification of 2-
nitromorphine and 2-nitromorphine-6-glucuronide in nitrite
adulterated urine specimens containing morphine and its
glucuronides. Drug Test. Anal. 2014, 6, 277.
[9] M. J. Bogusz, R. D. Maier, M. Erkens, U. Kohls. Detection of
non-presciption heroin markers in urine with liquid
chromatography-atmospheric pressure chemical ionisation
mass spectrometry. J. Anal. Toxicol. 2001, 25, 431.
[10] S. Paterson, R. Cordero. Comparison of the various opiate
alkaloid contaminants and their metabolites found in illicit
heroin with 6-monoacetyl morphine as indicators of heroin
ingestion. J. Anal. Toxicol. 2006, 30, 267.
[11] J. M. Oyler, E. J. Cone, R. E. Joseph, M. A. Huestis.
Identification of hydrocodone in human urine following
controlled codeine administration. J. Anal. Toxicol. 2000, 24, 530.
[12] C. M. Murphy, M. A. Huestis. LC-ESI-MS/MS analysis for
the quantification of morphine, codeine, morphine-3-β-D-
glucuronide, morphine-6-β-D-glucuronide, and codeine-6-
β-D-glucuronide in human urine. J. Mass Spectrom. 2005,
40, 1412.
[13] E. G. C. Clarke, A. C. Moffat, M. D. Osselton, B. Widdop.
Clarke’s Analysis of Drugs and Poisons. Pharmaceutical Press,
London, 2004.
[14] K. Minakata, K. Gonmori, N. Okamoto, H. Nozawa,
K. Watanabe, O. Suzuki. Rapid and sensitive identification
and determination of Urine Luck by ESI-MS after reduction
of chromate. Forensic Toxicol. 2006, 24, 48.
[15] W. B. Jaffee, E. Trucco, S. Levy, R. D. Weiss. Is this urine
really negative? A systematic review of tampering methods
in urine drug screening and testing. J. Subst. Abuse Treat.
2007, 33, 33.
[16] United Chemical Technologies. Opiates in urine – oxime TMS
procedure for GC or GC/MS confirmations using 200 mg
Clean Screen® extraction column, 2009 (cited 20/04/12).
SUPPORTING INFORMATION
Additional supporting information may be found in the
online version of this article at the publisher’s website.
wileyonlinelibrary.com/journal/rcm
Copyright © 2014 John Wiley & Sons, Ltd.
Rapid Commun. Mass Spectrom. 2014, 28, 1609–1620